INTRODUCTION Kit et al. (I963) obtained a line of L cells (LTK-
which were resistant to 5-bromodeoxyuridine (BUdR), an analogue of thymidine (TdR), and could be shown to lack thymidine kinase activity (TK). They demonstrated, by infecting these cells in the presence of BUdR with either vaccinia or herpes simplex virus (HSV) , that the yield of progeny virus in both cases was severely depressed. Moreover, they isolated mutants of both viruses which could grow equally well in these LTK-cells whether or not BUdR was present. Thus their studies suggested that the virus genome of both vaccinia and herpes simplex viruses contain information to code for thymidine kinase activity (TK). Subsequent biochemical investigations with HSV and LTK-cells suggested that the thymidine kinase found after infection differs from that found normally in host cells. Similar conclusions were reached by Klemperer et al. (I967) using BHK CI3 cells, who, in addition, showed that the enzyme induced after herpes virus infection was immunologically distinct from the host enzyme.
Meanwhile, Subak-Sharpe had selected a cell line derived from polyoma virus transformed BHK cells which lacked both deoxycytidine (dCK) and thymidine kinase activity (TK). The analogue used for selecting for loss of TK was BUdR and that used for selecting for loss of dCK was cytosine arabinoside (araC). It was found that dCK was produced in these cells by infection with HSV but not with vaccinia (Hay et al. I97O) . AraC resistant mutants of HSV were isolated and it was concluded that the dCK was a specific HSV coded polypeptide. Herpes simplex virus is not the only virus which induces deoxycytidine kinase activity: Kara & Weil (i967) have reported an increase in this activity following polyoma virus infection of mouse kidney cells, although this increased activity appears to be the result of derepression of a host specified activity. Hay et al. 0970) in the same series of experiments reported that the mutants selected for loss of thymidine kinase activity had simultaneously lost dCK activity, and conversely mutants selected for loss of dCK activity had also lost TK activity, which suggested that both enzyme activities were due to a common protein.
This unexpected finding prompted the present investigation and the experiments reported here are concerned with detailed genetical and biochemical investigation of HSV specified deoxycytidine and deoxythymidine kinase activities in these PyY[TG[CAR]BUdR cells. (Macpherson & Stoker, I962) grown in Eagle's medium containing (v/v) Io % tryptose phosphate broth and ~o % calf serum (ETC) were used for all virus plaque assays. The BUdR and araC resistant cells were originally obtained in our laboratory by one of us (J. H. Subak-Sharpe) as illustrated in Fig. I . A polyoma transformed clone of BHK Ci3 cells (PyY cells) was first selected for resistance to the purine analogue thioguanine (TG) in a single step by cloning cells which grew in o.2 #g/m1 of the analogue. These cells were then grown in increasing concentrations of araC from o.2 #g/ml up to 50 #g/ml and the survivors cloned. The cells were then exposed to 5 #g/ml BUdR and the survivors subjected to increasing concentrations of BUdR up to I mg[ml. Cell lines resistant to araC but not exposed to BUdR were cloned and stored at the end of the araC selection procedure (Fig. I) .
METHODS

Cell lines. BHK CI3 cells
In acquiring resistance to araC the ceils lost their ability to incorporate deoxycytidine, One step growth curve. 5o mm Petri dishes (Nunclon) containing confluent monolayers of cells were infected with virus at an input multiplicity of ~ o in a total vol. of o-z ml. After adsorption for ~ h at 37 °C, the cell sheet was washed, to remove unadsorbed virus, and 5 ml ECIo added. (In the case of resting cells the original ECr was replaced.) At subsequent times after infection the cell sheets were suspended in the medium and virus released by ultrasonic vibration. The liberated virus was then titrated for infectivity in BHK CI3 cells (Russell, I962 
Drug inhibition studies. PyY/TG[CAR/BUdR cells monolayers seeded 24 h previously at
~o 6 cells per plate were infected at an input multiplicity of I p.f.u.]cell. After one hour's adsorption at 37 °C excess virus was removed and 4 ml ECIo was added. When required, araC (z5 #g/ml) or BUdR (~ mg/ml) was added at this time. After 24 h incubation at 37 °C the cells were scraped into the medium and the resulting suspension treated in a sonifier. The sonicate was either stored at -7o °C or titrated immediately in BHK C I 3 cells.
Production of enzymes.
Revolving Winchester bottles containing a cell sheet which had just reached confluence, i.e. containing approx. BUdR) cells were infected at an input multiplicity of IO p.f.u./cell in 2o ml of ECIo and the virus allowed to adsorb at 37 °C for I h. Ioo ml ECIo was then added and incubation continued. Eight h after infection the cells were removed in so ml 1:4 trypsin versene. After all the cells had detached from the glass I ml of calf serum was added to neutralize the trypsin. The cells were then pelleted, washed twice in IO ml of ice cold saline and once in IO mM-tris, pH 7"5, containing 5 mM-mercaptoethanol, and 5 #M-thymidine/deoxycytidine. The cells were then resuspended in 5 ml buffer and disrupted by sonicating 4 × 3o s in the Dawe sonicator. The resulting sonicate was then centrifuged at IOOOOOg for I h. The supernatant fluid was removed and used as the crude enzyme fraction. The enzyme could be stored for long periods of' time at -70 °C.
Enzyme assays. The enzyme assay mixture contained in a final volume of IOO #1. ). After addition of the enzyme fraction, the tubes were shaken and incubated at 37 °C for 15 min except where explicitly stated. The reaction was stopped by immersing the mixtures in a boiling water bath, followed by cooling in ice.
Separation of the reaction products. Normally the phosphorylated compounds were separated from the nucleoside by spotting IO #1 of the reaction mixture on Whatman DE81 paper discs, which were then washed once in 4 raM-ammonium formate+ I O #M-TdR/CdR at 37 °C for 7 rain, once in 4 mM-ammonium formate at 37 °C for 7 rain, and once for 5 rain in distilled water at room temperature. The discs were finally rinsed in absolute alcohol, dried and counted J[n a scintillation spectrometer using a toluene based scintillant (2. 5 1 toluene, 12. 5 g PPO and o-I25 g POPOP).
Since the reaction mixture used in these experiments is essentially a crude one, the monophosphate will be further phosphorylated by nucleotide kinases in the enzyme preparation. Total separation of all the nucleotides formed in the reaction was achieved, using one or a combination of the following solvents. The standard solvent used to separate TdR derivatives was: butanol/glacial acetic acid/water, in a v/v ratio 2/I[ I. Initially this solvent was also used to separate CdR derivatives, but the picture here is complicated by the formation of deoxyuridine derivatives by contaminating dCMP deaminase present in the enzyme preparation. A pyridine/isopropanyl/glacial acetic acid/water solvent in a v/v ratio of 8/8[ I[4 was used to separate CdR, UdR, dCMP, and dUMP, while the separation of dCTP and dUTP was achieved using a pyridine/methanol/glacial acetic acid/water solvent in a v/v ratio of 6/6[T[4 (Gordon, Thornburg & Werum, I962) . All chromatography was performed by mixing 2o #l ,of the reaction mixture with Io #I of cold nucleotides (I mM), applying this mixture to Whatman No. I paper and running in descending chromatography for I6 h. After the paper had been air dried those run in the butanol solvent could be observed directly under u.v. light and the spots formed by the unlabelled controls added to the reaction mixture located. Chromatograms run in either of the pyridine solvents had to be washed extensively in CHC13 before the spots could be located. After location of the spots the chromatograms were cut into I cm strips, perpendicular to the direction of the solvent, and these strips counted as before.
RESULTS
Drug resistance of wiM type viruses
The replication of herpes simplex virus type I, is inhibited by both BUdR and araC, in PyY/TG/CAR/BUdR cells which themselves grow in the presence of and are fully resistant to both analogues. The 24 h yield of strain I7 syn virus is reduced to o.8 % and 5 % of the control in the presence of BUdR and araC, respectively (Table I a). Two other type I virus strains (34 Mp and Kit) were tested. They were found to be sensitive to both analogues, both being inhibited to the same extent as strain ~7 syn by BUdR, while strain 34 Mp showed five to tenfold greater sensitivity to araC than either of the other strainsl Herpes simplex type 2 shows a similar pattern of sensitivity to BUdR as the three type I strains and to araC as strains I7 syn and Kit (Table I a). The titres obtained after 24 h growth of HSV-2 in the presence of BUdR and araC were o'9 % and 5 % respectively of the control value.
The inhibition of virus replication caused by araC can be prevented by the simultaneous addition of approximately equimolar amounts of deoxycytidine, but cannot be reversed by addition of deoxycytidine four hours after the araC. However, the inhibition of virus replication by BUdR can not only be prevented by simultaneous addition of thymidine, but is at least partially reversed by the addition of thymidine four hours after infection (Table 2) .
When grown in PyY/TG/CAR[BUdR cells, pseudorabies virus and equine abortion
virus, two other members of the herpes group, exhibit patterns of response to BUdR and araC which differ from that of the herpes simplex viruses. Pseudorabies is sensitive to BUdR but totally resistant to araC, while equine abortion virus is resistant to both analogues (Table I b) . Vaccinia virus, chosen as a control outside the herpes group, is sensitive to BUdR but not to araC (Table I b) .
The resistance of pseudorabies virus to araC could reflect an insufficient concentration of the drug but this does not appear to be the explanation. At higher levels of araC the yield of pseudorabies virus is indeed slightly diminished, however, the effect is qualitatively not comparable to the effect on herpes simplex virus (Fig. 2) . Increasing concentrations of araC have little or no effect on either equine abortion, or vaccinia virus; neither does the addition of IO -5 M-5-fluorodeoxycytidine in conjunction with araC affect either virus, although on herpes simplex virus it produces a greater effect than does araC on its own.
Drug resistance of mutant viruses
Mutants of herpes simplex selected either for resistance to BUdR or to araC (as described in the Methods section) were tested for their ability to grow in the presence of either BUdR or araC. One mutant of each of the three type I strains and of the type 2 strain which were selected for resistance to BUdR were all found to have acquired simultaneous resistance to araC: similarly, each of the mutants selected for resistance to araC had at the same time acquired resistance to BUdR (Fig. 3) .
To investigate the generality of this finding many different mutants of HSV-I strain I7 syn which had been selected only for resistance to either BUdR or to araC were tested with both analogues. In all cases, irrespective of the analogue with which they had initially been selected, the mutants had simultaneously acquired resistance to both. Altogether forty mutants have been tested. The results obtained with a representative fourteen are shown in Fig. 4 Because all mutants of HSV selected for resistance to araC showed cross resistance to BUdR and vice versa, an attempt was made to derive mutant virus under conditions selective for resistance to araC, but against resistance to BUdR. These conditions were obtained by using PyY [TG[CAR[BUdR cells including in the medium araC, methotrexate (plus adenine as purine source), and TdR. The methotrexate makes virus DNA replication dependent on exogenous TdR by blocking dTMP synthetase. TK is required for anabolism of TdR, and therefore the production of virus progeny will depend on the ability of parental virus to code for TK. Inclusion of araC, in contrast ensures that the amount of virus progeny will be inversely proportional to the ability of parental virus to code for dCK. These conditions therefore should select for HSV which is dCK-TK +. Step Procedure I Mutagenizet HSV-t WT, BUdR, I ¢¢g/ml 2 Enrich~ progeny of step i 3 Enrich progeny of step 2 4
Enrich progeny of step 3 5
Enrich progeny of step 4 6 Enrich progeny of step 5 7
Plaque purify § progeny of step 6 into enrichment conditions (dCK-TK + ; 7 2 h) 8
Enrich progeny of step 7 9
Analyse progeny of step 8 for dCK and dTK markers * All titrations were done in BHK CI 3 cells, and expressed as p.f.u./ml.
Resulting titre* I'2 × 10 7 8"0 x I0 4 2"8 x 10 5 2' 5 x I0 ~ 6"4 × IO 6 2" 5 X 10 7 5'2 X 10 7 2.6 × IO 7 (see Table 5 ) * For mutagenization, BHK CI 3 cells (dCK + TK +) were infected with HSV-I, strain 17 syn (dCK + TK +) at an input multiplicity of approx. I p.f.u./cell. After absorption of virus (3o'), medium containing BUdR at a concentration of I/zg/ml (3 x io -n M) was added and the cells incubated at 37 °C for 24 h. After incubation, the monolayers were scraped, and the resulting suspension (4 ml) was sonicated, and titred in BHK C 13 cells.
:~ For enrichment, oq ml of the harvested virus was inoculated into dCK-TK-cells and incubated for 24 h in medium containing Io 4 M-araC, 25#g/ml; Io -6 M-methotrexate; 5 × Io-5 M-adenine; lO -5 i-glycine; and IO -s M-TdR. For each subsequent enrichment, o'I ml of the previous harvested infected cells was inoculated into dCK-TK-cells and the process repeated. When necessary between steps, virus was stored at --70 °C. § Ten plaques were picked from the titration of step 6, and inoculated immediately into enriching conditions (dCK-TK-cells, + araC, + TdR). After incubation at 37 °C for 72 h, the infected cells were harvested and the virus produced titred and enriched as described above. Although virus was obtained from each plaque picked, only one (clone id) was analysed further. 2'9 x 1o 6 araC dCK 5"2 × IO 6 6"7 × lo 7 * dCK-TK-cells were infected at an input multiplicity of approx, x p.f.u./cell; after absorption of virus, medium was added containing 3 × Io-3 M-BUdR, I mg/ml; or I × IO -4 M-araC 25/~g/ml; as indicated. The cells were incubated for 24 h at 37 °C, harvested, and the virus produced titred in BHK CI3 cells.
]" A reduction in titre with BUdR indicates TK activity; a reduction with araC indicates dCK. :~ Titre in p.f.u./ml of HSV-x, 17 syn, wild type. § Titre in p.f.u./ml of the progeny of step 8, Table 4 .
In Fig. 5 is shown the response of the system to the selection for TK +. Two features are clear. First, a relatively high concentration of TdR 0o -3 M) must be used in order to rescue wild type (TK +) HSV from the methotrexate block, and second, even then the selective pressure is not great; unrescued, the methotrexate does not depress virus production by quite I log. There is, nevertheless, a distinct advantage to having the TK + marker; this is further seen by the relative lack of effect of TdR rescue on the araC-resistant mutant of HSV used as control. The selective pressure against dCK is somewhat stronger. In dCK+ HSV grown in dCK-cells, araC ordinarily lowers the titre by between I and 2 logs (Fig.  3, 4) . To amplify the relatively weak selective pressure afforded by the system, virus mutagenized with BUdR was enriched for several passages in dCK-TK + selecting conditions before plaque purification, as described in Table 3 . The mutant thus isolated was analysed for the TK and dCK markers by comparing its resistance to araC and to BUdR with that of HSV-~ wild type. The results of this analysis, shown in Table 4 , shows that a partial mutant was obtained, somewhat more resistant to araC and BUdR than HSV-r wild type, but still much less so than HSV-I mutants isolated in our standard single-selective conditions for resistance to araC or BUdR.
Mutants of pseudorabies and vaccinia virus selected for resistance to BUdR remain as resistant to araC as the wild type virus. One passage of equine abortion virus in the presence of BUdR or araC (or of pseudorabies virus in the presence of araC) has no effect on the ability of the resulting progeny to replicate in the presence of either analogue.
Enzyme induction by wild type and mutant viruses
Both araC and BUdR express their toxicity only as phosphorylated compounds. Therefore resistance could be expected to be due to a lack of the appropriate deoxynucleoside kinase activity. On infection of PyY[TG[CAR/BUdR cells with HSV-I strain. I7 syn, a new thymidine kinase activity, can be demonstrated in vitro which phosphorylates thymidine to TMP. Because of the presence of other enzymes in the cell extract, TMP is further phosphorylated to TDP and TTP. The products of the in vitro reaction can be separated by partition chromatography on paper (Fig. 6) . Extracts from cells infected with mutant virus selected for either BUdR or araC resistance, or from mock-infected cells show essentially no thymidine kinase activity.
Extracts prepared from wild type herpes virus infected PyY/TG/CAR/BUdR cells also exhibit the ability to phosphorylate deoxycytidine to dCMP (Fig. 8) deoxycytidine kinase assay was found to migrate in a large peak near the origin (Fig. 7) On elution and re-running on a second chromatogram using a pyridine/methanol/water glacial acetic acid v/v ratio 6/6/4 / I solvent it could be separated into the nucleotides dCDP, dCTP and dUTP (Fig. 8) . These nucleotides represent the expected products formed by normal cellular enzymes like CMP kinase, dCDP kinase and dCMP deaminase, which are present in the crude enzyme extract. Wild-type viruses of the two other HSV-r strains (34 Mp and the Kit strain), as well as the HSV-2 strain, were found also to induce both thymidine and deoxycytidine kinase activities, while all the analogue resistant mutants of these strains which we have isolated and tested, lack the ability to induce either activity irrespective of the analogue against which they were selected (Table 5) .
After infection with pseudorabies virus there was an induction of thymidine kinase activity, but no increase in deoxycytidine kinase. Equine abortion virus, on the other hand induced neither a thymidine nor a deoxycytidine kinase activity. Vaccinia virus, as expected, induced a thymidine kinase activity, but there was no evidence of any deoxycytidine kinase activity (Table 6 ). Both pseudorabies and vaccinia virus mutants selected for resistance to
BUdR could no longer induce a thymidine kinase activity on infection of PyY[TG]CAR[
BUdR cells and they remained unable to phosphorylate deoxycytidine (Table 6 ).
Phosphorylation of thymidine and deoxycytidine by extracts of infected PyY/TG[CAR[
BUdR cells only takes place in the presence of ATP. Substitution of ATP by ADP or AMP fails to generate the phosphorylated deoxynucleotides (Table 7) . Distance migrated (cm) Fig. 8 . Separation of the components of peak A from the chromatogram in Fig. 7(a) . Fig. 9 ). In these three host systems the wild-type viruses grow well, although there are slight differences in the length of the growth cycle and in the actual yields. Thus BUdR-or araC-resistant HSV mutants, 
DISCUSSION
Herpes simplex viruses type I and type 2 are inhibited by either BUdR or araC in cells resistant to both compounds, and this inhibition has been correlated with the induction of a thymidine and a deoxycytidine kinase activity in the infected cells. When four virus strains were compared we found variation in susceptibility to araC. The reason for this is not established but these differences may simply reflect diversity at the molecular level between the enzyme proteins specified by the individual strains.
At the concentration of araC used in our experiments HSV-r and HSV-2 were inhibited to the same extent in PyY/TG/CAR/BUdR cells. Nutter & Rapp 0973) recently reported that HSV-I is more susceptible to araC than HSV-2 in rabbit kidney cells, and that at low araC concentrations in hamster embryo fibroblasts HSV-I and HSV-2 are equally susceptible. However, rabbit kidney cells as well as hamster embryo fibroblasts possess both kinase activities which suggests the possibility that the reported differences are a consequence of the host cell environment.
Within the herpes group there appears to be a wide spectrum of ability to induce these enzyme activities: at one extreme HSV induces both; pseudorabies virus only induces thymidine kinase; at the other extreme equine abortion virus induces neither thymidine nor deoxycytidine kinase. This finding is certainly both interesting and unexpected: whether it reflects different modes of natural infection or whether the explanation lies elsewhere remains to be established.
One unrelated DNA virus, vaccinia virus, was tested and found to induce only thymidine kinase activity after infection of cells lacking both thymidine and deoxycytidine kinase activities.
We have demonstrated that HSV mutants selected for ability to grow in the presence of BUdR also acquired the ability to grow in araC and conversely that mutants selected for growth in the presence of araC simultaneously gained resistance to BUdR. This result has been found to be true for three different type I and one type 2 strains. Moreover, 4 ° independently isolated mutants of HSV-r, strain I7 syn, all coincidentally acquired resistance to both base analogues. Our biochemical studies have established that resistance to BUdR and araC results from simultaneous loss by the mutants of the wild-type ability to induce thymidine and deoxycytidine kinase activities. These findings indicate that HSV not only induces both thymidine and deoxycytidine kinase activities, but that these two functions are genetically interrelated.
We will consider four molecular models which at first sight appear to be able to explain the situation: (I) HSV induces two different enzymes which have at least one essential subunit in common. (2) HSV induces two completely separate enzymes (which could be (a) virus, and (b) host coded) by means of the same virus specified controlling element. (3) HSV codes for one enzyme, which has separate active sites for the phosphorylation of thymidine and deoxycytidine. (4) HSV codes for one enzyme, which has one common active site for the phosphorylation of both substrates.
All mutants isolated from HSV-I strain I7 syn by selection for either BUdR or araC resistance turn out to lack the ability to induce both thymidine and deoxycytidine kinase activities. Even experiments specifically designed to maximize the chance of isolating dCK-TK + mutants only yielded a mutant with partial loss of both functions. We are forced to the conclusion that hypotheses (I), (2a) and (3) appear rather unlikely to be correct. If hypothesis (I) operates then it is difficult to understand why all the independently isolated mutants should have their defect in the protein subunit which is common to both the thymidine and deoxycytidine kinase and not sometimes in one or other of the not shared subunits. An analogous argument applies to hypothesis (2 a). As far as hypothesis (3) is concerned it is difficult to see why the occasional mutation inactivating only one of the active sites and not the other should not have been picked up. Of course it could be argued that the essential part of the individual sites, relative to the essential common part, is very much smaller and that not sufficient mutants have been checked. A further possibility involving mutational 'hot spots' will be discussed later.
The large number of mutants isolated which lack the ability to induce both activities, plus the fact that this constant relationship is observed in the three HSVq strains tested as well as in HSV-2 make it very unlikely that mutation in a controlling element, hypothesis (2a) or (2b), is the correct explanation. However, the virus gene coding for the controlling element or for the common subunit could contain a 'hot spot' for BUdR mutagenesis, and for this reason models (I) and (2), although they seem unlikely, cannot be totally rejected.
Thus the genetic evidence is really only fully consistent with hypothesis (4), that HSV specifies a unique deoxypyrimidine kinase, although hypotheses (I) to (3) are not completely ruled out. We have, however, obtained further biochemical evidence which strongly argues against hypotheses (I) and (2) The question remains why thymidine and deoxycytidine kinase activities are induced at all by HSV, which seems able to replicate efficiently without them in standard tissue culture systems. Our observation that mutant virus can grow in cells which lack both these enzyme activities but cannot replicate in serum starved cells, seems highly pertinent for it suggests that HSV requires deoxypyrimidine kinase activity under conditions where the host cells' de novo metabolism is low.
We consider it likely that the cells initially invaded in natural infections by herpes virus will have a low level of thymidilate metabolism and thus are more akin to resting than to nonresting cells. Our experiment therefore furnishes a plausible reason why HSV should code for deoxypyrimidine kinase activity.
If our finding that equine abortion virus does not code for any deoxypyrimidine kinase activity is confirmed for other strains of EAV then this suggests that since their evolutionary divergence from a common ancestor EAV and HSV have adapted to very different ecological niches even in terms of the stages in the cell cycle when these viruses are able to initiate a successful infectious cycle. Consistent with this hypothesis is the report by Lawrence (I97~) that EAV only replicates in tissue culture cells which are in S phase.
